Categories: News

The Assistance Fund Opens New Program for Chronic Obstructive Pulmonary Disease

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Chronic Obstructive Pulmonary Disease

ORLANDO, FL / ACCESSWIRE / May 13, 2024 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with chronic obstructive pulmonary disease (COPD). The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, coinsurance, and deductibles.

Chronic obstructive pulmonary disease is a chronic lung disease impacting millions of Americans each year. People living with COPD experience difficulty breathing, wheezing, and a daily cough.[1] Without treatment, the disease gets worse over time and can leave people requiring supplemental oxygen.

“People living with COPD should be focused on their health and wellbeing without the added worry of financial strain,” said Danielle Vizcaino, President and CEO of The Assistance Fund. “With the support of our donors, our COPD Copay Assistance Program removes many of the financial barriers patients face in accessing the critical treatment they need.”

To learn more or determine eligibility for financial support, visit tafcares.org or call (833) 543-2796 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages over 90 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped over 190,000 children and adults access the treatment they need to stay healthy or manage a life-threatening, chronic, or rare disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact

Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org

[1] Mayo Clinic, “Chronic Obstructive Pulmonary Disease,”https://www.mayoclinic.org/diseases-conditions/copd/symptoms-causes/syc-20353679, accessed April 2024.

SOURCE: The Assistance Fund

View the original press release on newswire.com.

Staff

Recent Posts

Is SynergyRx GLP-1 Legitimate? Platform Lists Compounded Semaglutide at $200 With Oral Tablet Options

Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…

4 hours ago

Direct Meds GLP-1 Medications Platform Maintains LegitScript Certification as New Year Weight Loss Interest Peaks Amid Compounding Regulatory Shifts

Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…

4 hours ago

Best Peptides for Boosting Growth Hormone: ReadyRx Lists Prescription Sermorelin in Injectable and Needle-Free Formats for 2026

Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…

4 hours ago

Best Fat Burner For Men 2026: Effective Fat Burning Supplements For Men’s Belly Fat Launched By Wolfson Brands Ltd

Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…

4 hours ago

MEDIROM Partners with World

Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…

4 hours ago